Article Details

Pfizer's hemophilia B gene therapy succeeds in late-stage study - ET HealthWorld

Retrieved on: 2022-12-29 14:55:39

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's hemophilia B gene therapy succeeds in late-stage study - ET HealthWorld. View article details on hiswai:

Excerpt

Pfizer S: Pfizer's therapy, fidanacogene elaparvovec, is designed to help patients produce factor IX themselves after a one-time treatment, ...

Article found on: health.economictimes.indiatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up